Product: CJC-1295 - 5 MG
Manufacture: EUROLABS PEPTIDES
Quantity: 5 MG
0,00 € Shipping
0,00 € Total
Human Growth Hormone by ST...
Human Growth Hormone Pharmatropin 10...
Contains20mg/tab x 50tb, 5blisters/box
Contains - 10 ml Blend of 3...
Titan Healthcare – Sus-250 – Sustanon...
Contains - 10 amp 1 amp - 1,5 ml
CJC-1295 - 5 MG | EUROLABS PEPTIDES
Introduction- Description and Uses
CJC-1295 is also referred as “Drug affinity complex growth releasing factor” abbreviated as DAC-GRF. It is a synthetic derivative of GHRH (Growth hormone releasing hormone) and available in the form of injectable peptide. Its sole objective is to increase the secretion of growth hormone alternate with corresponding pulses of somatostatin leading to the release of growth hormone inhibiting hormone. It basically promotes the release of IGF-1 and aids in fat loss and improved muscle gains. Its first clinical research experiment was piloted in mid-2000s and it became successful in reporting the fact that HGH production increased the rate of lipolysis (lipid breakdown) that resulted in the gut fat loss in obese patients of AIDS.
This analogue of GHRH is popular among body builders and athletes because of its fat burning and muscle strengthening abilities. Its mechanism of action is nearly similar to GHRH but the natural hormone cannot be manufactured into a performance enhancing drug due to its high cost of synthesis and extremely short duration of action. Therefore, CJC-1295 is a modified form having first 29 amino acids of the GHRH supplemented with DAC that has relatively long half-life that helps in maintaining stable blood levels after administration
Mechanism of action of CJC-1295:
CJC-1295 is a tetrasubstituted 30-amino acid peptide hormone that basically functions as a growth hormone-releasing hormone (GHRH) analog. It has substitutions of D-Ala, Gln, Ala and Leu at positions 2, 8, 15 and 27. GHRH-6 (growth hormone release peptide-6) is a hexapeptide with a 6 amino acid chain. It is one of several synthetic meta-enkephalin analogs that include unnatural D-amino acids that have been developed to release to growth hormone activity and are called growth hormone secretagogue. It has been shown to extend the half-life and bioavailability of growth-hormone-releasing hormone 1-29 and stimulate insulin-like growth factor secretion. It increases the half-life of acting agents by bioconjugation.
CJC-1295-5MG- Dosage and duration of the course
Advantages of using this drug medically and non-medically:
CJC-1295-5MG- Administration protocols
CJC-1295-5MG- Drug combinations
CJC-1295 modified form is usually stacked with GHRP-6 (growth hormone replacement peptides) for getting better results in terms of lean muscle mass, protein synthesis and loss of fat. If one injection of GHRP-6 is administered at night then it will not cause an increase in cortisol or prolactin.
The dosage for GHRP-6 will be 100 mcg or 50 mcg at a time if consuming hexarelin. Whereas, the dosage of CJC-1295 will be the same as described above. For a prolonged cycle, GHRP-6 can also be concurrently used with HGH (2-3 times daily)
CJC-1295-5MG- Clinical application/Treatment
It was initially used to treat muscle disorders and burn sufferers
CJC-1295-5MG- Side effects